← Leaderboards
Lance L Simpson
Thomas Jefferson University
$6,259,198
Attributed
$6,259,198
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $780.2K · FY2005–10$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$6,259,198 · 2
By mechanism
R01$6,259,198 · 2
Top collaborators
No co-investigators on record.
Most similar at Thomas Jefferson University
Same institution · by research overlap
- Jonathan Brody$5,162,616
- Dina Halegoua-Demarzio$1,136,701
Others in their field
Top investigators on “Botulinum Toxins”
- Milan Tomic · Xoma Corporation$38,826,613
- Raymond Kraker · Jaeb Center For Health Research, Inc.$22,955,213
- David Heimbrook · Leidos Biomedical Research, Inc.$21,781,988
- Kristina Simonyan · Massachusetts Eye And Ear Infirmary$21,604,913
- James D. Marks · University Of California San Francisco$16,571,771
- Konstantin Ichtchenko · New York University School Of Medicine$13,419,371
Research focus
Botulinum ToxinsLaboratory MouseVaccine DevelopmentTissue /Cell CultureProtein Structure FunctionTranscytosisChimeric ProteinsTetanus ToxinBiological TransportProtein EngineeringTransport ProteinsNeurotoxicologyImmunocytochemistryToxicant InteractionNeurotoxinsGastrointestinal Toxin AbsorptionCell LineGel ElectrophoresisBacterial ToxicologyChemical BindingEndocytosisNeuronal TransportImmunoconjugatesOral Administration
Grant awards (18)
Development of an Oral Carrier$318,361
R01 · FY2010 · GM · contact PI
Development of an Oral Carrier$321,576
R01 · FY2009 · GM · contact PI
Development of an Oral Carrier$321,576
R01 · FY2008 · GM · contact PI
Development of an Oral Carrier$322,444
R01 · FY2007 · GM · contact PI
Mechanism of Botulinum Toxin Action$470,826
R01 · FY2006 · NS · contact PI
Mechanism of Botulinum Toxin Action$468,111
R01 · FY2005 · NS
Development of Vaccine Carriers$312,098
R01 · FY2005 · GM
Mechanism of Botulinum Toxin Action$454,479
R01 · FY2004 · NS
Development of Vaccine Carriers$305,402
R01 · FY2004 · GM
Mechanism of Botulinum Toxin Action$78,500
R01 · FY2004 · NS
Mechanism of Botulinum Toxin Action$441,241
R01 · FY2003 · NS
Development of Vaccine Carriers$298,902
R01 · FY2003 · GM
MECHANISM OF BOTULINUM TOXIN ACTION$423,690
R01 · FY2002 · NS
Development of Vaccine Carriers$292,540
R01 · FY2002 · GM
MECHANISM OF BOTULINUM TOXIN ACTION$415,036
R01 · FY2001 · NS
DEVELOPMENT OF AN ORAL CARRIER$308,388
R01 · FY2001 · GM
MECHANISM OF BOTULINUM TOXIN ACTION$403,912
R01 · FY2000 · NS
DEVELOPMENT OF AN ORAL CARRIER$302,116
R01 · FY2000 · GM